Your Money & PoliticsGet crucial updates on rules and regulations that affect your money sent directly to your inbox.
Infrastructure stocks have been all the rage this year and they're only going to get hotter now that a new $2.3 trillion spending bill is being pushed in Washington.
Investors have been snapping up the shares of infrastructure stocks for some time now.
But it's not too late to buy if you know where to look.
Here are the best infrastructure stocks to buy ahead of this massive new spending...
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
The FDA's Schedule I label on cannabis is the single biggest barrier holding medical marijuana stocks back.
That barrier could be coming down soon, and you'll want to own shares of GW Pharmaceuticals when it does.
Lo and behold – a bill is moving through the U.S.
Senate to do just this.
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
Curaleaf stock will get a nice boost if this Senate bill passes.
And it's more than likely to happen.
Here's why you should be watching Curaleaf right now.
Let's talk about this bill, and then why Curaleaf is poised to benefit from its passage...
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
The Wall Street saying, “The trend is your friend” rings pretty true.
Indeed, when D.C.
sets trends – multibillion-dollar ones, to be exact – you better follow along or risk missing the boat.
That’s because policies move markets, and Shah’s seeing the smart money already on the move ahead of the administration’s $1.9 trillion “American Rescue Plan.” Today, he’ll show you a couple of ways to make sure you’re on the winning side… .
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
The first full week of a new administration is the perfect time to take a long view of what they want to change to align ourselves with the trillions of dollars that are about to flow through the huge U.S.
economy.
Shah will show you how to "follow the money" here….
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
History proves that there are going to be tons of moneymaking opportunities and profit catalysts with the Democrats running Washington… just as there were when the GOP was.
Only the nature of the opportunities will be different and today, Shah will show you how.
But red or blue, the end results will be the same: Green money in your pocket… .
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
Congress has finally gotten its act together and passed a stimulus package to support the economy.
That's welcome news.
You see, one of the great benefits of these stimulus checks is it's a great opportunity for stock buying.
Not only do investors have a bit more cash to sink into the market, but the boost to the market could create a windfall opportunity for the right stocks.
And we've got just the one to buy now...
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
As the Biden administration prepares to pour billions into American infrastructure, Chris Johnson is offering not one but two options recommendations to help you cash in BIG TIME on the shifting policy.
Click here to get the trade details on the latest edition of Fast Profits...
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
The anticipation is palpable… and building fast. We've had three reports on extremely effective upcoming coronavirus vaccines, and each report practically blows the last one out of the water.
First we heard preliminary reports that Pfizer and BioNTech's revolutionary messenger RNA (mRNA) coronavirus vaccine was 90% effective. That was great… until yesterday morning, when the biotechs got back in touch to say the real figure was something closer to 95%. And in the middle, we've heard from Moderna, which is reporting its mRNA vaccine is 94.5% effective.
Every time, stocks have taken off like a shot at the news; vaccines have helped push the Dow back above its February 2020 highs.
Here's the thing… setting aside the six vaccines The New York Times reports are in limited use in China and Russia – about which there are many unanswered questions – there are at least nine more coronavirus vaccines deep in phase 3, large-scale efficacy trials.
And there are no less than 55 more candidates in earlier, phase 1 and 2 trials. Some of these vaccine candidates won't advance, but others almost certainly will – two have already.
That all this has happened in less than a year is an "Apollo moonshot"-like scientific achievement. But that's also a whole lot of concentrated upside potential that could flood the markets and push stocks to almost unthinkable highs.
So I asked Money Morning Chief Investment Strategist Shah Gilani what it all means for us investors…
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
Given the central, critical role tech's will play in enduring and recovering from the pandemic, and moving on during Biden's tenure, the next four years could be even better than the last 12.
They could be some of the most profitable years ever for tech investors, and here's how Michael recommends we get started..
Start the conversation